Summary

The global Traumatic Brain Injury Therapeutics market size is predicted to grow from US$ 970 million in 2025 to US$ 1205 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.
Traumatic brain injury (TBI) is a nondegenerative, noncongenital insult to the brain from an external mechanical force, possibly leading to permanent or temporary impairment of cognitive, physical, and psychosocial functions, with an associated diminished or altered state of consciousness.
Traumatic brain injuries are usually emergencies and consequences can worsen rapidly without treatment. Doctors usually need to assess the situation quickly. Fast acting and effective tests to detect TBI will reduce hospital CT scans (the only current way to diagnose a TBI) by up to a third.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Traumatic Brain Injury Therapeutics Industry Forecast” looks at past sales and reviews total world Traumatic Brain Injury Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Traumatic Brain Injury Therapeutics sales for 2025 through 2031. With Traumatic Brain Injury Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Traumatic Brain Injury Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Traumatic Brain Injury Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Traumatic Brain Injury Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Traumatic Brain Injury Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Traumatic Brain Injury Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Traumatic Brain Injury Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Traumatic Brain Injury Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Acetylcholinesterase Inhibitors
Erythropoietin
Growth Hormone
Stem Cells
Others
Segmentation by Application:
Local TBI
Open TBI
Closed TBI
Diffuse TBI
Primary TBI
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SFC Fluidics LLC
Banayan Biomarkers Inc.
BHR Pharma LLC
Cerora Inc.
ElMindA Ltd.
Grace Laboratories LLC
KeyNeurotek Pharmaceuticals AG
Luoxis Diagnostics
Neuro Assessment Systems
Neurovive Pharmaceuticals AB
Oxygen Biotherapeutics Inc.
Phlogistix LLC
Neurohealing Pharmaceuticals
Neuren Pharmaceuticals Ltd.
Remedy Pharmaceuticals Inc.
Biodirection Inc.
Brainscope Company Inc.
TEVA Pharmaceutical Industries Ltd.
Vasopharm

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Traumatic Brain Injury Therapeutics Market Size (2020-2031)
2.1.2 Traumatic Brain Injury Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Traumatic Brain Injury Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Traumatic Brain Injury Therapeutics Segment by Type
2.2.1 Acetylcholinesterase Inhibitors
2.2.2 Erythropoietin
2.2.3 Growth Hormone
2.2.4 Stem Cells
2.2.5 Others
2.3 Traumatic Brain Injury Therapeutics Market Size by Type
2.3.1 Traumatic Brain Injury Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Traumatic Brain Injury Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Traumatic Brain Injury Therapeutics Segment by Application
2.4.1 Local TBI
2.4.2 Open TBI
2.4.3 Closed TBI
2.4.4 Diffuse TBI
2.4.5 Primary TBI
2.4.6 Others
2.5 Traumatic Brain Injury Therapeutics Market Size by Application
2.5.1 Traumatic Brain Injury Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Traumatic Brain Injury Therapeutics Market Size Market Share by Application (2020-2025)
3 Traumatic Brain Injury Therapeutics Market Size by Player
3.1 Traumatic Brain Injury Therapeutics Market Size Market Share by Player
3.1.1 Global Traumatic Brain Injury Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Traumatic Brain Injury Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Traumatic Brain Injury Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Traumatic Brain Injury Therapeutics by Region
4.1 Traumatic Brain Injury Therapeutics Market Size by Region (2020-2025)
4.2 Global Traumatic Brain Injury Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Traumatic Brain Injury Therapeutics Market Size Growth (2020-2025)
4.4 APAC Traumatic Brain Injury Therapeutics Market Size Growth (2020-2025)
4.5 Europe Traumatic Brain Injury Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Traumatic Brain Injury Therapeutics Market Size Growth (2020-2025)
5 Americas
5.1 Americas Traumatic Brain Injury Therapeutics Market Size by Country (2020-2025)
5.2 Americas Traumatic Brain Injury Therapeutics Market Size by Type (2020-2025)
5.3 Americas Traumatic Brain Injury Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Traumatic Brain Injury Therapeutics Market Size by Region (2020-2025)
6.2 APAC Traumatic Brain Injury Therapeutics Market Size by Type (2020-2025)
6.3 APAC Traumatic Brain Injury Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Traumatic Brain Injury Therapeutics Market Size by Country (2020-2025)
7.2 Europe Traumatic Brain Injury Therapeutics Market Size by Type (2020-2025)
7.3 Europe Traumatic Brain Injury Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Traumatic Brain Injury Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Traumatic Brain Injury Therapeutics Market Forecast
10.1 Global Traumatic Brain Injury Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Traumatic Brain Injury Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Traumatic Brain Injury Therapeutics Forecast
10.1.3 APAC Traumatic Brain Injury Therapeutics Forecast
10.1.4 Europe Traumatic Brain Injury Therapeutics Forecast
10.1.5 Middle East & Africa Traumatic Brain Injury Therapeutics Forecast
10.2 Americas Traumatic Brain Injury Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Traumatic Brain Injury Therapeutics Forecast
10.2.2 Canada Market Traumatic Brain Injury Therapeutics Forecast
10.2.3 Mexico Market Traumatic Brain Injury Therapeutics Forecast
10.2.4 Brazil Market Traumatic Brain Injury Therapeutics Forecast
10.3 APAC Traumatic Brain Injury Therapeutics Forecast by Region (2026-2031)
10.3.1 China Traumatic Brain Injury Therapeutics Market Forecast
10.3.2 Japan Market Traumatic Brain Injury Therapeutics Forecast
10.3.3 Korea Market Traumatic Brain Injury Therapeutics Forecast
10.3.4 Southeast Asia Market Traumatic Brain Injury Therapeutics Forecast
10.3.5 India Market Traumatic Brain Injury Therapeutics Forecast
10.3.6 Australia Market Traumatic Brain Injury Therapeutics Forecast
10.4 Europe Traumatic Brain Injury Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Traumatic Brain Injury Therapeutics Forecast
10.4.2 France Market Traumatic Brain Injury Therapeutics Forecast
10.4.3 UK Market Traumatic Brain Injury Therapeutics Forecast
10.4.4 Italy Market Traumatic Brain Injury Therapeutics Forecast
10.4.5 Russia Market Traumatic Brain Injury Therapeutics Forecast
10.5 Middle East & Africa Traumatic Brain Injury Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Traumatic Brain Injury Therapeutics Forecast
10.5.2 South Africa Market Traumatic Brain Injury Therapeutics Forecast
10.5.3 Israel Market Traumatic Brain Injury Therapeutics Forecast
10.5.4 Turkey Market Traumatic Brain Injury Therapeutics Forecast
10.6 Global Traumatic Brain Injury Therapeutics Forecast by Type (2026-2031)
10.7 Global Traumatic Brain Injury Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Traumatic Brain Injury Therapeutics Forecast
11 Key Players Analysis
11.1 SFC Fluidics LLC
11.1.1 SFC Fluidics LLC Company Information
11.1.2 SFC Fluidics LLC Traumatic Brain Injury Therapeutics Product Offered
11.1.3 SFC Fluidics LLC Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 SFC Fluidics LLC Main Business Overview
11.1.5 SFC Fluidics LLC Latest Developments
11.2 Banayan Biomarkers Inc.
11.2.1 Banayan Biomarkers Inc. Company Information
11.2.2 Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Product Offered
11.2.3 Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Banayan Biomarkers Inc. Main Business Overview
11.2.5 Banayan Biomarkers Inc. Latest Developments
11.3 BHR Pharma LLC
11.3.1 BHR Pharma LLC Company Information
11.3.2 BHR Pharma LLC Traumatic Brain Injury Therapeutics Product Offered
11.3.3 BHR Pharma LLC Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BHR Pharma LLC Main Business Overview
11.3.5 BHR Pharma LLC Latest Developments
11.4 Cerora Inc.
11.4.1 Cerora Inc. Company Information
11.4.2 Cerora Inc. Traumatic Brain Injury Therapeutics Product Offered
11.4.3 Cerora Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Cerora Inc. Main Business Overview
11.4.5 Cerora Inc. Latest Developments
11.5 ElMindA Ltd.
11.5.1 ElMindA Ltd. Company Information
11.5.2 ElMindA Ltd. Traumatic Brain Injury Therapeutics Product Offered
11.5.3 ElMindA Ltd. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 ElMindA Ltd. Main Business Overview
11.5.5 ElMindA Ltd. Latest Developments
11.6 Grace Laboratories LLC
11.6.1 Grace Laboratories LLC Company Information
11.6.2 Grace Laboratories LLC Traumatic Brain Injury Therapeutics Product Offered
11.6.3 Grace Laboratories LLC Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Grace Laboratories LLC Main Business Overview
11.6.5 Grace Laboratories LLC Latest Developments
11.7 KeyNeurotek Pharmaceuticals AG
11.7.1 KeyNeurotek Pharmaceuticals AG Company Information
11.7.2 KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Product Offered
11.7.3 KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 KeyNeurotek Pharmaceuticals AG Main Business Overview
11.7.5 KeyNeurotek Pharmaceuticals AG Latest Developments
11.8 Luoxis Diagnostics
11.8.1 Luoxis Diagnostics Company Information
11.8.2 Luoxis Diagnostics Traumatic Brain Injury Therapeutics Product Offered
11.8.3 Luoxis Diagnostics Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Luoxis Diagnostics Main Business Overview
11.8.5 Luoxis Diagnostics Latest Developments
11.9 Neuro Assessment Systems
11.9.1 Neuro Assessment Systems Company Information
11.9.2 Neuro Assessment Systems Traumatic Brain Injury Therapeutics Product Offered
11.9.3 Neuro Assessment Systems Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Neuro Assessment Systems Main Business Overview
11.9.5 Neuro Assessment Systems Latest Developments
11.10 Neurovive Pharmaceuticals AB
11.10.1 Neurovive Pharmaceuticals AB Company Information
11.10.2 Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Product Offered
11.10.3 Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Neurovive Pharmaceuticals AB Main Business Overview
11.10.5 Neurovive Pharmaceuticals AB Latest Developments
11.11 Oxygen Biotherapeutics Inc.
11.11.1 Oxygen Biotherapeutics Inc. Company Information
11.11.2 Oxygen Biotherapeutics Inc. Traumatic Brain Injury Therapeutics Product Offered
11.11.3 Oxygen Biotherapeutics Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Oxygen Biotherapeutics Inc. Main Business Overview
11.11.5 Oxygen Biotherapeutics Inc. Latest Developments
11.12 Phlogistix LLC
11.12.1 Phlogistix LLC Company Information
11.12.2 Phlogistix LLC Traumatic Brain Injury Therapeutics Product Offered
11.12.3 Phlogistix LLC Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Phlogistix LLC Main Business Overview
11.12.5 Phlogistix LLC Latest Developments
11.13 Neurohealing Pharmaceuticals
11.13.1 Neurohealing Pharmaceuticals Company Information
11.13.2 Neurohealing Pharmaceuticals Traumatic Brain Injury Therapeutics Product Offered
11.13.3 Neurohealing Pharmaceuticals Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Neurohealing Pharmaceuticals Main Business Overview
11.13.5 Neurohealing Pharmaceuticals Latest Developments
11.14 Neuren Pharmaceuticals Ltd.
11.14.1 Neuren Pharmaceuticals Ltd. Company Information
11.14.2 Neuren Pharmaceuticals Ltd. Traumatic Brain Injury Therapeutics Product Offered
11.14.3 Neuren Pharmaceuticals Ltd. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Neuren Pharmaceuticals Ltd. Main Business Overview
11.14.5 Neuren Pharmaceuticals Ltd. Latest Developments
11.15 Remedy Pharmaceuticals Inc.
11.15.1 Remedy Pharmaceuticals Inc. Company Information
11.15.2 Remedy Pharmaceuticals Inc. Traumatic Brain Injury Therapeutics Product Offered
11.15.3 Remedy Pharmaceuticals Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Remedy Pharmaceuticals Inc. Main Business Overview
11.15.5 Remedy Pharmaceuticals Inc. Latest Developments
11.16 Biodirection Inc.
11.16.1 Biodirection Inc. Company Information
11.16.2 Biodirection Inc. Traumatic Brain Injury Therapeutics Product Offered
11.16.3 Biodirection Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Biodirection Inc. Main Business Overview
11.16.5 Biodirection Inc. Latest Developments
11.17 Brainscope Company Inc.
11.17.1 Brainscope Company Inc. Company Information
11.17.2 Brainscope Company Inc. Traumatic Brain Injury Therapeutics Product Offered
11.17.3 Brainscope Company Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Brainscope Company Inc. Main Business Overview
11.17.5 Brainscope Company Inc. Latest Developments
11.18 TEVA Pharmaceutical Industries Ltd.
11.18.1 TEVA Pharmaceutical Industries Ltd. Company Information
11.18.2 TEVA Pharmaceutical Industries Ltd. Traumatic Brain Injury Therapeutics Product Offered
11.18.3 TEVA Pharmaceutical Industries Ltd. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 TEVA Pharmaceutical Industries Ltd. Main Business Overview
11.18.5 TEVA Pharmaceutical Industries Ltd. Latest Developments
11.19 Vasopharm
11.19.1 Vasopharm Company Information
11.19.2 Vasopharm Traumatic Brain Injury Therapeutics Product Offered
11.19.3 Vasopharm Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Vasopharm Main Business Overview
11.19.5 Vasopharm Latest Developments
12 Research Findings and Conclusion